Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ezatul E. Kamarulzaman, Régis Vanderesse, Amirah M. Gazzali, Muriel Barberi-Heyob, Cédric Boura, Céline Frochot, Omar Shawkataly, André Aubry & Habibah A. Wahab. (2017) Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application. Journal of Biomolecular Structure and Dynamics 35:1, pages 26-45.
Read now
Read now
Articles from other publishers (15)
Kosuke Shimizu & Naoto Oku. 2019. Cancer Drug Delivery Systems Based on the Tumor Microenvironment. Cancer Drug Delivery Systems Based on the Tumor Microenvironment
187
216
.
Tatsuya Fukuta, Tomohiro Asai, Yuri Kiyokawa, Takashi Nakada, Koji Bessyo-Hirashima, Natsuki Fukaya, Kenji Hyodo, Kazuma Takase, Hiroshi Kikuchi & Naoto Oku. (2017) Targeted delivery of anticancer drugs to tumor vessels by use of liposomes modified with a peptide identified by phage biopanning with human endothelial progenitor cells. International Journal of Pharmaceutics 524:1-2, pages 364-372.
Crossref
Crossref
Kosuke Shimizu. (2017) Development of New Liposome Targeting Strategies for Application of Disease Therapiesリポソームを用いた新たな標的化戦略と疾患治療への応用. YAKUGAKU ZASSHI 137:1, pages 43-48.
Crossref
Crossref
Kosuke Shimizu. (2016) Challenge to the development of diagnostic and therapeutic drugs using liposomal drug delivery systems：8<sup>th</sup> Young Scientist Award, Japan Society of DDS. Drug Delivery System 31:4, pages 352-360.
Crossref
Crossref
You‐Xin Zhou, Xiong‐Hui Chen, Xue‐Shun Xie, Yu‐Lun Huang, Zhi‐Mou Xue, Gui‐Lin Chen, Zhong Wang, Jin‐Ming Chen, Zuo‐Peng Su & Zi‐Wei Du. (2012) Orthotopic model of SHG‐44 in the enhanced green fluorescent protein nude mouse. Journal of Neuroscience Research 90:9, pages 1814-1819.
Crossref
Crossref
Chen Zhong, Xiangdong Zhou, Minghui Zhang & Yide Hu. (2011) Anti-angiogenesis effect of Demethyl bryoanthrathiophene (DBT) in vitro. The Chinese-German Journal of Clinical Oncology 10:2, pages 63-69.
Crossref
Crossref
Hans-Eckhardt SchaeferHans-Eckhardt Schaefer. 2010. Nanoscience. Nanoscience
615
735
.
Chikezie O. Madu & Yi Lu. 2009. Pharmaceutical Perspectives of Cancer Therapeutics. Pharmaceutical Perspectives of Cancer Therapeutics
1
47
.
Qingyuan ZhangXinmei KangBaofeng YangJingxuan WangFang Yang. (2008) Antiangiogenic Effect of Capecitabine Combined with Ginsenoside Rg3 on Breast Cancer in Mice. Cancer Biotherapy and Radiopharmaceuticals 23:5, pages 647-654.
Crossref
Crossref
Tomohiro Asai, Souichiro Miyazawa, Noriyuki Maeda, Kentaro Hatanaka, Yasufumi Katanasaka, Kosuke Shimizu, Satoshi Shuto & Naoto Oku. (2008) Antineovascular therapy with angiogenic vessel-targeted polyethyleneglycol-shielded liposomal DPP–CNDAC. Cancer Science 99:5, pages 1029-1033.
Crossref
Crossref
Tomohiro Asai, Yuko Suzuki, Saori Matsushita, Sei Yonezawa, Junichi Yokota, Yasufumi Katanasaka, Tatsuhiro Ishida, Takehisa Dewa, Hiroshi Kiwada, Mamoru Nango & Naoto Oku. (2008) Disappearance of the angiogenic potential of endothelial cells caused by Argonaute2 knockdown. Biochemical and Biophysical Research Communications 368:2, pages 243-248.
Crossref
Crossref
Kosuke Shimizu, Yasuharu Sawazaki, Toshiki Tanaka, Tomohiro Asai & Naoto Oku. (2008) Chronopharmacologic Cancer Treatment with an Angiogenic Vessel-Targeted Liposomal Drug. Biological and Pharmaceutical Bulletin 31:1, pages 95-98.
Crossref
Crossref
Michael I. Dorrell, Edith Aguilar, Lea Scheppke, Faith H. Barnett & Martin Friedlander. (2007) Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis. Proceedings of the National Academy of Sciences 104:3, pages 967-972.
Crossref
Crossref
G. Ramachandra Reddy, Mahaveer S. Bhojani, Patrick McConville, Jonathan Moody, Bradford A. Moffat, Daniel E. Hall, Gwangseong Kim, Yong-Eun L. Koo, Michael J. Woolliscroft, James V. Sugai, Timothy D. Johnson, Martin A. Philbert, Raoul Kopelman, Alnawaz Rehemtulla & Brian D. Ross. (2006) Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors. Clinical Cancer Research 12:22, pages 6677-6686.
Crossref
Crossref
Jaroslav Sterba, Dalibor Valik, Peter Mudry, Tomas Kepak, Zdenek Pavelka, Viera Bajciova, Karel Zitterbart, Vera Kadlecova & Pavel Mazanek. (2006) Combined Biodifferentiating and Antiangiogenic Oral Metronomic Therapy is Feasible and Effective in Relapsed Solid Tumors in Children: Single-Center Pilot Study. Oncology Research and Treatment 29:7, pages 308-313.
Crossref
Crossref